These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4429976)

  • 21. [Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA; Iverson MT
    Arq Bras Cardiol; 1984 Jun; 42(6):435-41. PubMed ID: 6393921
    [No Abstract]   [Full Text] [Related]  

  • 22. Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():551s-554s. PubMed ID: 1071679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prindolol in the management of hypertension.
    Seedat YK
    N Z Med J; 1974 May; 79(515):945-6. PubMed ID: 4527941
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypotensive effect and characteristics of the effect on the central hemodynamics of the delayed-action form of diltiazem (Dilren) in patients with hypertension].
    Pshenitsin AI; Glotov MN; Mazur NA
    Ter Arkh; 1993; 65(9):47-50. PubMed ID: 8303596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
    Mattioli G; Ricci S; Menozzi A; Teglio V
    Minerva Cardioangiol; 1982 Mar; 30(3):81-8. PubMed ID: 6123962
    [No Abstract]   [Full Text] [Related]  

  • 27. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C
    Arzneimittelforschung; 1983; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract]   [Full Text] [Related]  

  • 28. A controlled study of prindolol (Visken) in hypertension.
    Thorpe P
    Med J Aust; 1972 Aug; 2(6):306-9. PubMed ID: 4563156
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparative study of the effect of LB-46 and propranolol on central haemodynamic in cases with angina pectoris.
    Duner H; Pernow B
    Indian Heart J; 1972 Jun; 24():Suppl 1:180-2. PubMed ID: 4667014
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term haemodynamic effects of enalapril at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    Scand J Urol Nephrol Suppl; 1984; 79():87-91. PubMed ID: 6089323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of long-term training and treatment on the blood pressure and performance of hypertonic subjects (author's transl)].
    Chrástek J; Soucková E; Matousek O
    Sb Lek; 1977 Apr; 79(4):113-9. PubMed ID: 854704
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical effect of beta-adrenergic blockers in the treatment of hypertension with regard to a decrease in peripheral resistance].
    Trifunović S
    Lijec Vjesn; 1984; 106(11-12):526-30. PubMed ID: 6151619
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long term study (1 year) with a beta receptor blocker-diuretic combination in hypertension treatment].
    Gotzen R; Faupel RP; Hammerschmidt D
    Med Welt; 1981 Sep; 32(39):1450-2. PubMed ID: 7029197
    [No Abstract]   [Full Text] [Related]  

  • 39. Elevated plasma catecholamines in young hypertensive and hyperkinetic patients: effect of pindolol.
    Dominiak P; Grobecker H
    Br J Clin Pharmacol; 1982; 13(Suppl 2):381S-390S. PubMed ID: 7104155
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.